Difficulty of Diagnosing Alzheimer's Disease

Introduction and Background

Introduction

Alzheimer's disease is a progressive neurodegenerative disorder that affects memory, thinking, and behavior. It is the most common cause of dementia, accounting for up to 80% of all dementia cases (Rayathala et al., 2022). While Alzheimer's disease affects both men and women, research has shown that women are disproportionately affected by the disease (Rabipour et al., 2021). Women have a higher risk of developing Alzheimer's disease than men, and they also tend to experience more rapid cognitive decline once they develop the disease (Duarte-Guterman et al., 2021).

Background

The challenges of making an early diagnosis of Alzheimer's disease have been documented (Pais et al., 2020). However, why these challenges exist is not particularly well understood (Dubois et al., 2021). Early diagnosis is crucial because it allows for early intervention and treatment, which can slow the progression of the disease and improve quality of life for patients and their families (Rasmussen & Langerman, 2019). However, making an early diagnosis of Alzheimer's disease can be particularly challenging for women (Ferretti et al., 2020).

It is unclear why early diagnosis of Alzheimer’s for women is challenging for physicians, but a challenge it certainly is (Dubois et al., 2021). Researchers have, however, presented different theories as to why this challenge exists, including atypical presentation, delayed presentation, bias in research, and differences in brain structure and function (Duara & Barker, 2022; Lopez et al., 2020).

Duara and Barker (2022) argue that women may present with atypical symptoms that are not always recognized as being related to Alzheimer's disease. For example, women may be more likely to experience mood changes, anxiety, and sleep disturbances than men, which could be mistaken for other conditions. Or, women may be more likely to delay seeking medical attention for cognitive symptoms or may not report them at all due to social stigma or shame. This can delay the diagnosis and treatment of Alzheimer's disease (Lopez et al., 2020). Also, historically, Alzheimer's disease research has been biased towards studying men, leading to a lack of understanding of how the disease manifests in women (Ferretti et al., 2020). This can result in misdiagnosis or delayed diagnosis of Alzheimer's in women. Finally, studies have shown that women's brains may be more resilient to the effects of Alzheimer's disease, making it harder to detect the disease in its early stages (Veitch et al., 2022). Plus, women may have a higher burden of certain types of Alzheimer's-related brain changes, such as tau tangles, which can be harder to detect with current diagnostic tools (Veitch et al., 2022).

Relevance and Importance

The topic of the challenges of making an early diagnosis of Alzheimer's disease in women is both relevant and important for several reasons. First, as the population ages, the number of cases of Alzheimer's disease is expected to increase significantly, and women will be disproportionately affected (Dubois et al., 2021). Second, early diagnosis is crucial for effective treatment and care, and the challenges of making an early diagnosis in women must be addressed to improve outcomes for patients and their families (Dubois et al., 2021; Rasmussen & Langerman, 2019). Third, the topic is of theoretical importance because it highlights the complex interplay between gender, health, and aging, and raises important questions about how healthcare systems can address these issues. More can be said, however, on the value of this research in terms of practical, empirical, and theoretical importance.

Practical Importance

Practically, the ability to accurately diagnose Alzheimer's disease is critical to providing appropriate treatment and care to patients. If physicians are not able to accurately diagnose Alzheimer's disease in women, this can result in delayed treatment, misdiagnosis, and suboptimal care. Accurate diagnosis can also help patients and their families plan for the future and make informed decisions about their care.

Empirical Importance

Empirically, understanding the factors that contribute to diagnostic challenges in women with Alzheimer's disease can help inform the development of more effective diagnostic tools and strategies (Duarte-Guterman et al., 20210. It can also help improve our understanding of the disease itself, including its presentation and progression in different populations. This can lead to better treatment options and improved outcomes for patients.

Theoretical Importance

Theoretically, the topic of diagnosing Alzheimer's disease in women is important because it sheds light on broader issues related to health disparities and gender bias in medicine (Lopez et al., 2020). It highlights the need for more research and attention to be paid to how diseases present differently in different populations, and the need for more inclusive research practices that account for diversity and inclusivity in medical research.

Prior Research

Prior research has shown that women are more likely than men to develop Alzheimer's disease, and that they experience more rapid cognitive decline once they develop the disease (Duarte-Guterman et al., 2021). Some studies have also suggested that women may be more sensitive to the effects of Alzheimer's disease pathology in the brain (Duara & Barker, 2022; Lopez et al., 2020). However, research on the challenges of making an early diagnosis of Alzheimer's disease in women is limited (Dubois et al., 2021).

Problem Statement

The challenges of making an early diagnosis of Alzheimer's disease in women are significant and multifaceted. There is a need for more research to understand the specific challenges that women face in receiving an early diagnosis of Alzheimer's disease, and to develop effective strategies for addressing these challenges. This study seeks to address this need by exploring the challenges of making an early diagnosis of Alzheimer's disease in women, and through that exploration making inroads into potentially developing new strategies that can improve early diagnosis and treatment for this population.

References

Duara, R., & Barker, W. (2022). Heterogeneity in Alzheimer’s disease diagnosis and progression

rates: Implications for therapeutic trials. Neurotherapeutics, 19(1), 8-25.

Duarte-Guterman, P., Albert, A. Y., Barha, C. K., Galea, L. A., & Alzheimer’s Disease

Neuroimaging Initiative. (2021). Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memory. Psychoneuroendocrinology, 129, 105248.

Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., ... & Feldman,